Journal of Liver Cancer

Yun Hwan Kim

4 Articles

A Case of Hepatocellular Carcinoma with Bile Duct Invasion: Yeon Seok Seo, Beom Jin Park, Yun Hwan Kim, Soon Ho Um; Journal of the Korean Liver Cancer Study Group. 2008;8(1):69-73. Published online June 30, 2008

Abstract PDF: Cholestatic type hepatocellular carcinoma (HCC), in which obstructive jaundice is presented as the initial presentation of HCC, is rare. The prognosis of cholestatic type HCC is generally poor and most of the patients die from cholangitis or sepsis. Although some authors reported cases of successfully treated cholestatic type HCC with surgical resection, most of the patients are inoperable at the time of diagnosis. Several reports suggested that transarterial chemoembolization (TACE) showed a beneficial effect in improving the survival time and therefore, TACE should be tried as a first choice of therapy in patients with cholestatic HCC with sufficient liver reserve function. We experienced a case of obstructive jaundice as the initial presentation of HCC. His obstructive jaundice showed significant improvement after several sessions of TACE.

A Case of Hepatocellular Carcinoma with Combined Treatment: Eun Sun Kim, Yeon Seok Seo, Hyun Chul Kim, Yun Hwan Kim, Soon Ho Um; Journal of the Korean Liver Cancer Study Group. 2008;8(1):111-114. Published online June 30, 2008

Abstract PDF: Hepatocellular carcinoma (HCC) is an aggressive tumor that frequently occurs in the setting of chronic liver disease and cirrhosis. It is typically diagnosed late in the course of chronic liver disease, with the median survival following diagnosis of approximately 6 to 20 months. Although the mainstay of therapy is surgical resection, several other treatment modalities may also have a role. The patient’s hepatic reserve often dictates therapeutic options. Treatment options are divided into surgical therapies (i.e., resection, cryoablation, and orthotopic liver transplantation), and nonsurgical therapies (i.e., percutaneous ethanol injection, radiofrequency ablation, transarterial chemoembolization, systemic chemotherapy, or radiotherapy). Here we report a case of successfully treated HCC with combined therapy of surgical and nonsurgical modalities.

Hypovascular Hepatocellular Carcinoma Supposed to Originate from Dysplastic Nodule: Nam Young Jo, Soon Ho Um, Kum Won Kim, Yun Hwan Kim, Nam Hee Won; Journal of the Korean Liver Cancer Study Group. 2003;3(1):87-91. Published online July 31, 2003

Abstract PDF: Hepatocellular carcinoma (HCC) typically shows hepatic arterial phase contrast-enhancement and wash out pattern at portal phase. Hepatic dysplastic nodules show diverse imaging characteristics but commonly show hypoattenuation pattern at CT-imaging. We report an 3 cm sized atypical hypovascular HCC which was thought to orginate from dysplastic nodule. Fifty senven year old female who had suffered from chronic hepatitis B had three separate hepatic nodules initially. One in seg 7 diagnosed as well-differentiated HCC, another in seg 5 as dysplastic nodule by US guided needle biopsy. Remaining 1.5 cm sized nodule in seg 4 which showed isoattenuation at arterial phase and hypoattenuation at portal phase. We avoid invasive treatment to seg 4 nodule due to vicinity of great vessel. We performed transarterial chemoembolization (TACE) and percutaneous ethanol injection to the seg 7 & seg 5 lesions and followed up with TACE. At 2 years later the nodule in seg 4 grew up to 3 cm sized mass with showed persistency no arterial phase enhancement and partially hypoattenuating-isoattenuating pattern at portal phase. The mass diagnosed as clear cell type HCC (Edmoson grade Ⅱ) by US guided biopsy.

Radiological Findings of Hypovasscular Hepatocellaler Carcinoma: Hwan Hoon Chung , Yun Hwan Kim; Journal of the Korean Liver Cancer Study Group. 2001;1(1):20-28. Published online June 30, 2001